Cardiel, Mario H.
Carrillo, Sandra
Pérez, Marcela
Andrade, Lilia
Pacheco Tena, César
Silveira, Luis H.
Limón, Leonardo
Cerpa, Sergio
Gutiérrez Ureña, Sergio
Durán, Sergio
Irazoque Palazuelos, Fedra
Muñoz López, Sandra
Sicsik Ayala, Sandra Araceli
Barile, Leonor
Ramos Sánchez, María Azucena
Grajeda Portes, Daniel
Portela, Margarita
Hernández Bedolla, Alina
García-Figueroa, José Luis
Montero, Mauricio
Abud-Mendoza, Carlos
Martínez Martínez, Marco Ulises
Herrera van Ostdam, David
Pascual-Ramos, Virginia
Merayo-Chalico, Javier
Guzmán-Sánchez, Istar
Pérez-Bastidas, María Esther
Aguilar Arreola, Jorge Enrique
López Rodríguez, Alejandra
Reyes-Cordero, Greta
Ricardez, Humberto Alfredo
Hernández Cabrera, María Fernanda
Olvera-Soto, Guadalupe
Xibillé Friedmann, Daniel
Funding for this research was provided by:
Mexican College of Rheumatology AC
This article is maintained by: Elsevier
Article Title: Update of the Mexican College of Rheumatology guidelines for the pharmacological treatment of rheumatoid arthritis, 2018
Journal Title: Reumatología Clínica (English Edition)
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2019.04.001
CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2019.04.002
Content Type: article
Copyright: © 2019 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.